SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp slide alongside a broader crypto selloff has put key support levels and continued downside in focus. Traders are split between treating the oversold decline as a buying opportunity and fearing a deeper break, with some pointing to inflation-driven rate concerns and leveraged liquidations as pressure on crypto markets.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,738,272,860.16806072. The last known price of Dogecoin is 0.06457313 USD and is down -2.71 over the last 24 hours. It is currently trading on 1545 active market(s) with $672,498,596.98 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a prolonged selloff alongside broader crypto weakness, with traders voicing frustration and warning of further declines. Some holders are buying the dip and citing possible bullish chart signals, but that optimism is contested by bearish calls and concerns that interest in the coin is fading.

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ionis is drawing attention after quarterly results included a sharp cut to TRYNGOLZA sales guidance amid a slower-than-expected launch, overshadowing otherwise solid results and reaffirmed total-revenue guidance. Traders are debating whether the selloff reflects real commercial-execution concerns or an overreaction, with some buying the dip as shares attempt to stabilize.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is drawing attention ahead of the FDAs PDUFA decision on ivonescimab plus chemotherapy for EGFR-mutant lung cancer, with traders framing it as a binary approval-versus-CRL event. Bulls point to strong progression-free-survival results and improving overall-survival trends, while bears focus on the missed statistical-significance threshold for overall survival and the FDAs stated requirement; some speculate recent selling signals bad news, while others say the price action proves nothing.

HawKeye 360, Inc. engages in the provision of defense technology. It offers spectrum monitoring, maritime intelligence, air defence radar monitoring, GNSS interference detection, and communications mapping. Its costumers include a wide range of commercial, government and international entities. The company was founded by Charles T. Clancy, Robert G. McGwier, Chris DeMay and John Serafini in 2015 and is headquartered in Herndon, VA.

HawkEye 360 Inc.

Record Q3 results and raised full-year guidance are driving attention, with traders citing strong revenue growth, international contract wins, and the companys space-based signals-intelligence business. The reaction is broadly bullish, though some discussion focuses on whether the sharp rise can hold and on valuation.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins sharp selloff and weakening support have pressured IBIT, with traders debating whether the decline signals a deeper crypto downturn or an oversold pullback that could rebound. Bearish calls for further losses compete with dip-buying optimism.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,407,571,868.045494 in circulation. The last known price of Stellar is 0.14587805 USD and is down -1.99 over the last 24 hours. It is currently trading on 848 active market(s) with $216,910,874.56 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention amid persistent selling and bearish technical commentary, with traders debating whether the weakness reflects broader crypto-market pressure or continued underperformance. Bulls cite Stellars reported DTCC and real-world-asset tokenization plans as longer-term catalysts, while skeptics argue that adoption news has yet to translate into meaningful token demand or price gains.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff toward the high-$60Ks has traders focused on broken support and whether the decline will deepen. Bearish posts warn of further losses, while dip buyers point to oversold conditions and argue a rebound may be near; cited explanations such as rising yields, ETF outflows, and competition for IPO capital remain trader speculation.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,079,719,016.041028 in circulation. The last known price of Algorand is 0.08513994 USD and is down -2.94 over the last 24 hours. It is currently trading on 586 active market(s) with $61,102,468.95 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs weakness near multi-year lows is driving debate, with bearish traders warning of further downside and questioning the tokens adoption and economics, while bullish holders describe the pullback as a buying opportunity and continue accumulating. The discussion also references Algorands quantum-security upgrades and new leadership, but price direction and whether a bottom is in remain the dominant focus.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FUBOs steep, low-volume slide to fresh lows is driving discussion, with bearish traders citing weak demand and persistent selling while bulls call the shares oversold. The debate centers on whether earnings and CEO Alisa Bowens strategic plan can show that the Disney/Hulu integration will improve growth and profitability.

statis crypto Watchlist

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


BuIl2030

Sir Makes-A-Lot